Takahiro Kobayashi

9PUBLICATIONS
27CO-AUTHORS
Molecular targetsMedical virologyGene and molecular therapyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2025
Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpression.

Wataru Kuroki, Akihiro Kitadate, Yuto Takahashi

|Mar 01, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Yasunori Kogure, Hiroshi Handa, Yuta Ito

|Feb 09, 2024
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.

Honami Sato, Takahiro Kobayashi, Yoshihiro Kameoka

|Aug 13, 2022
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.

Honami Sato, Takahiro Kobayashi, Nanako Fujita

|Aug 05, 2022
EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress.

Jiro Kikuchi, Nobuyuki Kodama, Masataka Takeshita

|Jan 02, 2021
Correlation between increased immune checkpoint molecule expression and refractoriness to blinatumomab evaluated by longitudinal T cell analysis.

Takahiro Kobayashi, Kumi Ubukawa, Masumi Fujishima

Pageof 2

Frequent Collaborators

3 joint publications

Naoto Takahashi

1 joint publications

Nobuyuki Kodama

1 joint publications

Masataka Takeshita

1 joint publications

Hiroshi Yasui